Suchergebnisse - "Bi, Youwei"

PubPharm (40)

1

FDA Approval Summary : Dabrafenib in Combination with Trametinib for BRAFV600E Mutation-Positive Low-Grade Glioma

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2024

von Barbato, M. | Nashed, J. | Bradford, D. | +17

2

Experience Learned and Perspectives on Using Model-Integrated Evidence in the Regulatory Context for Generic Drug Products-a Meeting Report

enthalten in: The AAPS journal | 2024

von Tsakalozou, E. | Fang, L. | Bi, Y. | +6

3

Experience Learned and Perspectives on Using Model-Integrated Evidence in the Regulatory Context for Generic Drug Products—a Meeting Report

enthalten in: The AAPS Journal | 2024

von Tsakalozou, E. | Fang, L. | Bi, Y. | +6

4

Model-Informed Approaches to Support Drug Development for Patients With Obesity : A Regulatory Perspective

enthalten in: Journal of clinical pharmacology | 2023

von Pan, X. | Wang, L. | Liu, J. | +7

5

How to select the initial dose for a pediatric study?

enthalten in: Journal of biopharmaceutical statistics | 2023

von Ye, J. | Bi, Y. | Ting, N.

6

FDA Approval Summary : Tucatinib with Trastuzumab for Advanced Unresectable or Metastatic, Chemotherapy Refractory, HER2-Positive RAS Wild-Type Colorectal Cancer

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2023

von Casak, S. | Horiba, M. | Yuan, M. | +12

7

FDA Approval Summary : Futibatinib for Unresectable Advanced or Metastatic, Chemotherapy Refractory Intrahepatic Cholangiocarcinoma with FGFR2 Fusions or Other Rearrangements

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2023

von Gandhy, S. | Casak, S. | Mushti, S. | +17

8

FDA Approval Summary : Selpercatinib for the Treatment of Advanced RET Fusion-Positive Solid Tumors

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2023

von Duke, E. | Bradford, D. | Marcovitz, M. | +19

9

US Food and Drug Administration Approval Summary : Nivolumab Plus Platinum-Doublet Chemotherapy for the Neoadjuvant Treatment of Patients With Resectable Non-Small-Cell Lung Cancer

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2023

von Akinboro, O. | Drezner, N. | Amatya, A. | +11

10

FDA Approval Summary : Mobocertinib for Metastatic Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2023

von Duke, E. | Stapleford, L. | Drezner, N. | +24